PT UBC Medical Indonesia Tbk (IDX:LABS)
Indonesia · Delayed Price · Currency is IDR 143.00
+1.00 (0.70%)
Oct 30, 2025, 3:49 PM WIB
IDX:LABS Revenue
PT UBC Medical Indonesia Tbk had revenue of 53.23B IDR in the quarter ending June 30, 2025, with 48.73% growth. This brings the company's revenue in the last twelve months to 169.80B. In the year 2024, PT UBC Medical Indonesia Tbk had annual revenue of 147.64B with 8.00% growth.
Revenue (ttm)
169.80B
Revenue Growth
+8.00%
P/S Ratio
3.33
Revenue / Employee
2.74B
Employees
62
Market Cap
564.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 147.64B | 10.94B | 8.00% |
| Dec 31, 2023 | 136.70B | 43.41B | 46.53% |
| Dec 31, 2022 | 93.29B | -36.67B | -28.22% |
| Dec 31, 2021 | 129.96B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition